A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer.
about
Potential role for metformin in urologic oncologyRepurposing metformin for cancer treatment: current clinical studiesEnergy disruptors: rising stars in anticancer therapy?Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human StudiesNutrition, dietary interventions and prostate cancer: the latest evidenceMATE2 Expression Is Associated with Cancer Cell Response to MetforminMetformin effects on biochemical recurrence and metabolic signaling in the prostate.Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer.Highlights of the university of toronto urology update 2014.Measuring the biological effect of presurgical metformin treatment in endometrial cancer.Repurposing old drugs to chemoprevention: the case of metformin.The Relationship Between Metformin and Serum Prostate-Specific Antigen LevelsDesigns of preoperative biomarkers trials in oncology: a systematic review of the literature.Bioactivity and prostate tissue distribution of metformin in a preprostatectomy prostate cancer cohort.Repurposing metformin for the prevention of cancer and cancer recurrence.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.Metformin and Prostate Cancer: a New Role for an Old Drug.A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.Metformin and prostate cancer mortality: a meta-analysis.Germline BRCA mutation in male carriers-ripe for precision oncology?Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome.Metformin: an anti-proliferative agent and methylation regulator in treating prostatic disease?Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
P2860
Q26747759-6D1036DC-480F-44BB-A92F-1CE54FB169F4Q26752651-B6A35C65-AC14-4DCE-8062-1DFBD687BCF2Q26771300-EA58535F-B17E-4EAC-BA3C-9B7F07E1D2C8Q28081491-EC06021B-583E-473E-9380-9EDF60E53CCEQ28084566-B78ACFCF-2702-4E4A-8918-9287DD852B8DQ28555000-0FA6BE92-701F-4597-A211-6E81ECE785A9Q30665188-6426299A-4362-4FC5-B7AF-7E151B506939Q33921635-68A7497C-B8F8-4DE9-943A-4277B3B69747Q35100023-B900DD48-40F7-4429-9A75-C234BE886C8AQ36547907-4609BE1F-9977-43C6-A760-701D1157FBCFQ36679911-C363D537-FCE8-4501-97AD-B8852819EA5FQ37316486-88B7FCB0-3B0A-4AF6-8476-3C52D3425AE8Q38586993-A9A3CA95-844B-4B33-9967-04D44E345474Q38660247-9B80BC65-2FD7-4F35-BB49-5D387771F4FFQ38695734-99B24853-0C3D-4B50-8E55-74E21FF58B8AQ38728567-147DF51E-6810-40C4-ADF0-FDF3A03A7A57Q38819039-D182C4F9-6A21-4DBC-9870-BC9E674EF9FEQ39124486-BF94040D-A69F-4E7D-98C9-4D2593282515Q41149937-505E3C50-0D47-4771-8823-CEB48399CFA2Q46798905-DC66FE1F-69CA-426E-9AE0-B418E9D4D466Q47769995-D6B7B857-135E-4111-9E3A-764AB753CCF5Q50103863-12F2D97D-47BF-4D74-AC80-25BB1466E275Q58696780-A505A1DC-1B32-4900-8C5B-510CBF97B0AF
P2860
A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
A pilot 'window of opportunity ...... in localised prostate cancer.
@en
A pilot 'window of opportunity ...... in localised prostate cancer.
@nl
type
label
A pilot 'window of opportunity ...... in localised prostate cancer.
@en
A pilot 'window of opportunity ...... in localised prostate cancer.
@nl
prefLabel
A pilot 'window of opportunity ...... in localised prostate cancer.
@en
A pilot 'window of opportunity ...... in localised prostate cancer.
@nl
P2093
P2860
P50
P356
P1476
A pilot 'window of opportunity ...... n in localised prostate cancer
@en
P2093
J Trachtenberg
M R Downes
N Fleshner
V E Zannella
P2860
P2888
P304
P356
10.1038/PCAN.2014.20
P577
2014-05-27T00:00:00Z